Science Explorer Back to mapMap
Discussion
Institution · Pearl River Community College

Most cited papers from Pearl River Community College

Pearl River Community College

What are the most cited papers from Pearl River Community College?

The most cited paper from Pearl River Community College is "Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success" (Frank Lovering, Jack Andrew Bikker, Christine C. Humblet, 2009), with 4,568 citations. Next come "Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat" (2,640) and "The evolving role of natural products in drug discovery" (2,586).

Showing 50 of 60 papers. Every paper with more than 213 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success Frank Lovering, Jack Andrew Bikker, Christine C. Humblet · Journal of Medicinal Chemistry 14 Oct 2009 4,568
2 Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat Patricia A. Bradford · Clinical Microbiology Reviews Open access Oct 2001 2,640
3 The evolving role of natural products in drug discovery Frank E. Koehn, Guy T. Carter · Nature Reviews Drug Discovery Review 24 Feb 2005 2,586
4 The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol Emmanuel J. H. J. Wiertz, Thomas R. Jones, Lei Sun et al. · Cell Open access Mar 1996 1,090
5 A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection Keith P. Klugman, Shabir Ahmed Madhi, Robin E. Huebner et al. · New England Journal of Medicine Open access Oct 2003 1,018
6 Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I William P. Hausdorff, John Bryant, Peter R. Paradiso et al. · Clinical Infectious Diseases 2000 872
7 Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals David M. Shlaes, Dale N. Gerding, Joseph F. John et al. · Clinical Infectious Diseases Open access Sep 1997 787
8 Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery Mei-Chu Lo, ANN E. AULABAUGH, Guixian Jin et al. · Analytical Biochemistry 2 Jun 2004 701
9 Transcription Profiling-Based Identification of Staphylococcus aureus Genes Regulated by the agr and/or sarA Loci Paul M. Dunman, Ellen Murphy, Staci L. Haney et al. · Journal of Bacteriology 15 Dec 2001 647
10 Aluminum compounds as vaccine adjuvants Gupta Rk · Advanced Drug Delivery Reviews 6 Jul 1998 629
11 Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products Gopi Shankar, Viswanath Devanarayan, Lakshmi S. Amaravadi et al. · Journal of Pharmaceutical and Biomedical Analysis 20 Sep 2008 609
12 Global Gene Expression in Staphylococcus aureus Biofilms Karen E. Beenken, Paul M. Dunman, Fionnuala McAleese et al. · Journal of Bacteriology Open access Jul 2004 587
13 A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling Tatsushi Muta, Tomohiro Kurosaki, Ziva Misulovin et al. · Nature 3 Mar 1994 586
14 A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine KLEMENS STEHR, James D. Cherry, Ulrich Heininger et al. · PEDIATRICS 1998 513
15 Why is big Pharma getting out of antibacterial drug discovery? Steven J. Projan · Current Opinion in Microbiology 16 Sep 2003 503
16 Combinatorial chemoprevention of intestinal neoplasia Christopher J. Torrance, Peta E. Jackson, Elizabeth Anne Montgomery et al. · Nature Medicine Sep 2000 496
17 Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York City Patricia A. Bradford, Simona Bratu, Carl M. Urban et al. · Clinical Infectious Diseases 21 Jun 2004 488
18 The ER-Luminal Domain of the HCMV Glycoprotein US6 Inhibits Peptide Translocation by TAP Kwangseog Ahn, Albrecht Gruhler, Begoña Galocha et al. · Immunity Open access May 1997 484
19 Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein Patricia A. Bradford, Carl M. Urban, N Mariano et al. · Antimicrobial Agents and Chemotherapy Open access Mar 1997 453
20 mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Ker Yu, Lourdes Toral‐Barza, Carolyn M. Discafani et al. · Endocrine Related Cancer Open access Sep 2001 421
21 Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Thomas R. Jones, Emmanuel J. H. J. Wiertz, Lei Sun et al. · Proceedings of the National Academy of Sciences Open access 15 Oct 1996 416
22 SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice. Jennifer M. Golas, Kim T. Arndt, Carlo Etienne et al. · PubMed 15 Jan 2003 415
23 In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936) Peter J. Petersen, Nilda V. Jacobus, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy Open access Apr 1999 413
24 Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors Richard F. Squires, Donald I. Benson, Claus Bræstrup et al. · Pharmacology Biochemistry and Behavior May 1979 411
25 Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants Luis Jódar, Jay C. Butler, George M. Carlone et al. · Vaccine 7 Apr 2003 389
26 Channeling of Substrates and Intermediates in Enzyme-Catalyzed Reactions Xinyi Huang, Hazel M. Holden, Frank M. Raushel · Annual Review of Biochemistry Review Jun 2001 380
27 Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies George R. Siber, Ih Chang, Sherryl A. Baker et al. · Vaccine 22 Feb 2007 373
28 Carbapenem-hydrolyzing beta-lactamases B A Rasmussen, Karen Bush · Antimicrobial Agents and Chemotherapy Open access Feb 1997 360
29 Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines D D Ross, Weidong Yang, Lynne V. Abruzzo et al. · JNCI Journal of the National Cancer Institute Open access 3 Mar 1999 353
30 Prognostic relevance of the mTOR pathway in renal cell carcinoma Allan J. Pantuck, David B. Seligson, Tobias Klatte et al. · Cancer 17 Apr 2007 351
31 Vaccine Potential of theNeisseria meningitidis2086 Lipoprotein Leah D. Fletcher, Liesel Bernfield, Vicki L. Barniak et al. · Infection and Immunity Open access 23 Mar 2004 336
32 Targeting the mTOR signaling network in cancer Gary Gene Chiang, Robert T. Abraham · Trends in Molecular Medicine Review Oct 2007 335
33 The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II William P. Hausdorff, John Bryant, C. Kloek et al. · Clinical Infectious Diseases Open access 2000 334
34 Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon Sugunya Utaida, Paul M. Dunman, Daphne Macapagal et al. · Microbiology Oct 2003 331
35 Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products Eugen Koren, Holly W. Smith, Elizabeth W. Shores et al. · Journal of Immunological Methods 30 Jan 2008 328
36 Mechanisms of protein stabilization in the solid state Liuquan Chang, Michael Jon Pikal · Journal of Pharmaceutical Sciences Open access 30 Jun 2009 326
37 Automated analysis of protein NMR assignments using methods from artificial intelligence Diane E. Zimmerman, Casimir A. Kulikowski, Yuanpeng Janet Huang et al. · Journal of Molecular Biology Jun 1997 313
38 Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy Peter F. Wright, Ruth A. Karron, Robert B. Belshe et al. · The Journal of Infectious Diseases Nov 2000 308
39 Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity Hwei‐Ru Tsou, Elsebe G. Overbeek-Klumpers, William Andrew Hallett et al. · Journal of Medicinal Chemistry Open access 27 Jan 2005 302
40 Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. Tomohiro Kurosaki, Minoru Takata, Yuji Yamanashi et al. · The Journal of Experimental Medicine Open access May 1994 294
41 Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid Dodi Goldman, W C Pickett, Edward J. Goetzl · Biochemical and Biophysical Research Communications Nov 1983 293
42 Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants Ruth A. Karron, Peter F. Wright, Robert B. Belshe et al. · The Journal of Infectious Diseases 12 Mar 2005 287
43 Evidence for two apoptotic pathways in light-induced retinal degeneration Wenshan Hao, Andreas Wenzel, Martin S. Obin et al. · Nature Genetics 3 Sep 2002 287
44 Multidrug Resistance in Staphylococcus aureus Due to Overexpression of a Novel Multidrug and Toxin Extrusion (MATE) Transport Protein Glenn William Kaatz, Fionnuala McAleese, Susan M. Seo · Antimicrobial Agents and Chemotherapy Open access 26 Apr 2005 285
45 Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1 Charles R. Dean, Melissa A. Visalli, Steven J. Projan et al. · Antimicrobial Agents and Chemotherapy Open access 25 Feb 2003 284
46 Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells Roman Tomazin, Jessica M. Boname, Nagendra R. Hegde et al. · Nature Medicine Sep 1999 279
47 Isolation and Characterization of Novel Marine-Derived Actinomycete Taxa Rich in Bioactive Metabolites Nathan A. Magarvey, Jessica M. Keller, Valerie S. Bernan et al. · Applied and Environmental Microbiology Open access Dec 2004 277
48 Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2) Allan Wissner, Elsebe Overbeek, Marvin F. Reich et al. · Journal of Medicinal Chemistry Open access 2 Dec 2002 267
49 Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children Bruce D. Forrest, Michael W. Pride, Andrew J. Dunning et al. · Clinical and Vaccine Immunology Open access May 2008 256
50 SarA, a Global Regulator of Virulence Determinants inStaphylococcus aureus, Binds to a Conserved Motif Essential for sar-dependent Gene Regulation Yueh‐tyng Chien, Adhar C. Manna, Steven J. Projan et al. · Journal of Biological Chemistry Open access Dec 1999 253

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.